The acquisition is expected to cost almost €65 million and will secure domestic pharmaceutical capacity, in peacetime and in times of crisis.

View original content: https://www.prnewswire.com/news-releases/acurx-pharmaceuticals-inc-announces-exercise-of-warrants-for-2-67-million-gross-proceeds-302484551.html ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) ...

As previously reported, 15 out of 16 (94%) patients in Phase 2b in the Per Protocol Population experienced Clinical Cure (CC) and all 15 of 15 (100%) remained free ...

Gut health is becoming central to preventive healthcare in India. Personalised approaches combining traditional and modern ...

Dermatologists are prescribing algae skincare that repairs damaged skin at cellular level. Why marine extracts beat synthetic ...

Drugmakers want more clarity from the Trump administration on the potential pharmaceutical tariffs, which some companies warn ...

The newest innovation, “Steer in a Year,” is a whole-cow subscription model, over 400 pounds of Texas-raised beef delivered ...

Explore once-popular foods from the 1970s that are now banned—see what vanished from shelves and why these nostalgic bites ...

Before the surgery could happen, she had to go through a bunch of tests over a few months with various specialists. After all ...